How COVID-19 has affected Medtronic, Stryker, Johnson & Johnson's shares over the last month

Eric Oliver -   Print  |

Despite bans on elective orthopedic procedures, large device companies have successfully pivoted to weather the COVID-19 pandemic.

Here's how Medtronic, Stryker and Johnson & Johnson shares have fluctuated over the last month.

Note: Becker's is using final numbers at market close for each day unless otherwise noted.

Medtronic:
April 1: $84.11
April 6: $94.06
April 13: $99.52
April 20: $101.54
April 27: $100.76
Percent change: 19.8 percent

Stryker:
April 1: $144.67
April 6: $165.66
April 13: $172.08
April 20: $184.72
April 27: $191.96
Percent change: 32.69 percent

Johnson & Johnson (DePuy Synthes)
April 1: $128.81
April 6: $139.76
April 13: $139.77
April 20: $151.67
April 27: $154.29
Percent change: 19.78 percent

More articles on surgery centers:
Life after ramp-up: How COVID-19 will change ASCs forever
3 ASC nurses join COVID-19 front lines in New York
4 hospitals, health systems opening ASCs

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers